Attenuated strain of myxoma virus for use as an oncolytic drug
US8613915B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 11, 2010 |
| Grant date | Dec 24, 2013 |
| Priority date | — |
| Expiry date | Jul 25, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/24032
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of an attenuated vaccinal strain of Myxoma virus, in particular the SG33 strain, as an oncolytic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.